Tag: immunotherapy for TNBC

Triple-Negative Breast Cancer: Modern Treatment Strategies and Ongoing Clinical Trials

By : Tamsin Riverton
Date : Jan 28 2026

Triple-negative breast cancer (TNBC) is aggressive and hard to treat, but new therapies like immunotherapy, PARP inhibitors, and personalized vaccines are changing outcomes. Learn the latest treatment strategies and clinical trials shaping care in 2026.